How to Write Manuscripts (Module 18)

Wednesday, February 1, 2023, 8:00 AM - Friday, January 30, 2026, 11:59 PM

AMA PRA Category 1 Credits™ (3.00 hours), AMA PRA Category 1 Credits™ Designated (3.00 hours)

Ophthalmology Faculty Development Webcast Series

Goal: The goal of this lecture is to gain self-confidence and develop skills and knowledge in translating practice into a manuscript to publish.

Course Format: This is a self-led series independent modules. Participants can choose to participate in the entire series, or choose to join the modules that will be most useful to them. Each module in the series will be released consecutively on the first week of each month (July, 2021 onward). Modules consist of a recorded asynchronous presentation with activities and assessment.

Course Director: Karl Golnik, MD, MEd
Activity Coordinator: Eduardo Mayorga, MD
Program Manager/Administrative Support: Jodi Hicks

For more information about this series or for IT support, please contact the program manager.

This series is offered at no cost.

To access the course content, please click on the link: https://ophthalmologyfoundation.org/teaching_skills/

1. Translate a study into a story.
2. Describe at least three article designs;
3. Describe the IMRAD structure;
4. Translate clinical education practice into writing opportunities.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, The Ophthalmology Foundation & the PAAO. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 3.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships with Ineligible Entities

IIn accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24-months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education, or whose conflicts of interests cannot be mitigated.

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant relationships have been mitigated. The following planning members disclosures were made:

Planning Committee Members

Karl C. Golnik, MD, MEd, Course Director - No relationships
Eduardo Mayorga, MD, Course Coordinator - No relationships
Helena Filipe, MD, MMEd - No relationships
Gabriela Palis, MD, MEd - No relationships
Ashley Elliott, Administative Support - (Stock) Axsome Therapeutics, Inc., Global Blood Therapeutics, Inc., Health Care Select Sector SPDR Fund, Novartis AG, Pfizer, Viatris, Inc.
Heather Muskopf, CME Office - No relationships

Disclaimer Statement
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

Faculty Disclosure Declaration
According to the disclosure policy of the University of Cincinnati, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies within the last 24-months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosure will be made at the time of activity.

Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

COI / Disclosure of Relationships with Ineligible Entities

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24-months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education, or whose conflicts of interests cannot be mitigated.

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant relationships have been mitigated. The following planning members disclosures were made:

Faculty Disclosures:

Zelia M. Correa, MD, PhD (Nothing to disclose)
Professor of Ophthalmology 
Director, Ocular Oncology Service
Medical Director of Echography
Bascom Palmer Eye Institute, University of Miami
Miami, Florida

Heather G. Mack, MBBS, PhD, FRANZCO (Nothing to disclose)
Clinical Associate Professor of Ophthalmology, University of Melbourne
Centre for Eye Research, University of Australia
Senior Associate, Eye Surgery Associates
Melbourne, Australia

Fatima Pedrosa Domellof, MD (Nothing to disclose)
Professor of Ophthalmology, Dept of Clinical Science, Umeå Universitet
Senior Consultant Ophthalmologist, Overlakare, Umeå University Hospital
Slädvägen, Umeå, Sweden

Sashwanthi Mohan, MBBS, DNB, FICO, MRCS (Nothing to disclose)
Ophthalmologist and Vitreoretinal Specialist
Chennai, Tamilnadu, India

Ana Silva, PhD (Nothing to disclose)
Lecturer & Researcher
Expert Reviewer for EU Commission
Marinhais, Portugal

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.